Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

3D bioprinting with special hydrogels helps heal wounds and grow new blood vessels.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Key proteins and pathways regulate yak hair growth, with lipid metabolism aiding adaptation to high altitudes.

JAK inhibitors show promise for treating various skin diseases.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Higher STAT3 levels are found in hair loss areas, but not linked to hair loss severity.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Stem cell niches are essential for tissue health and repair.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

JAK inhibitors are effective treatments for alopecia areata.